Clinical trial
Study of Pamidronate for the Prevention of Heterotopic Ossification
NCT00262392 · University Hospital, Basel, Switzerland, Other · Withdrawn
Key facts
| NCT number | NCT00262392 |
|---|---|
| Title | Study of Pamidronate for the Prevention of Heterotopic Ossification |
| Official title | Study Into the Effect of Pamidronate for the Prevention of Heterotopic Ossification in High-risk Patients: A Randomized Controlled Trial |
| Lead sponsor | University Hospital, Basel, Switzerland, Other |
| Collaborators | FAG (Freie Medizinische Gesellschaft) |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Heterotopic Ossification |
| Intervention type | Drug |
| Interventions | Pamidronate (AREDIA) |
| Enrollment | 0 |
| Start date | Jun 1, 2005 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Dec 6, 2005 |
| Last update posted | Mar 10, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: